Why did the FDA ban many peptides in 2023, and are they being considered for legalization again?

The FDA banned popular peptides, moving them to Category 2, citing insufficient data for safety. However, there is news that the FDA will consider legalizing seven peptides, including BPC-157, in July.

What are the benefits of peptides like BPC-157 and TV500?

BPC-157 is known for enhancing blood vessel growth and aiding healing, proving highly effective in animal models. TV500, a derivative, improves blood flow to injured areas by stimulating the cells needed for tissue repair.

How are people accessing peptides that are currently banned or only available for research?

Many people access these peptides through the 'gray market,' where companies sell them labeled 'for research use only' to bypass FDA jurisdiction. However, this lacks quality control and carries risks.

What are the benefits of GLP-1 peptides like semaglutide and tirzepatide?

GLP-1 drugs are highly effective for significant weight loss and improving metabolic health. They also aid in slowing gastric emptying, preventing glucose spikes, and can indirectly improve male fertility by reducing obesity and insulin resistance.

Can you explain the difference between patented pharmaceutical peptides and compounded versions?

Patented versions, like Mounjaro (tirzepatide), are standardized and approved for specific uses. Compounded versions offer flexibility in dosing and can include modifications like niacinamide, but face regulatory scrutiny from pharmaceutical companies concerned about competition.

What are the potential downsides or trade-offs of using peptides?

A major trade-off is the uncertainty of quality and purity when sourcing unregulated peptides. Additionally, some peptides can have side effects, like tesamorelin causing temporary regain if lifestyle changes aren't made or melanotan 2 potentially stimulating melanoma.

What is retatrutide and why is it considered the 'Ferrari' of GLP-1 medications?

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Clinical trials and anecdotal reports show dramatic body composition changes with 20-25% weight loss and significant liver health improvements, making it highly anticipated.

How do peptides like GHK-CU benefit the skin?

GHK-CU is a copper tripeptide that, when applied topically, is effective in regenerating skin quality, increasing collagen and elastin, and improving complexion, thereby helping to slow the visual signs of aging.

What are the primary concerns about rapid weight loss from GLP-1 medications?

Rapid weight loss can lead to catabolism, where the body breaks down muscle tissue instead of just fat. Maintaining muscle is crucial for insulin sensitivity, and alternatives like myostatin inhibitors are being developed.

What is the physician's personal experience with peptides and health optimization?

The physician shared a personal journey of physical and psychological toll from medical training. He now prioritizes self-care and uses peptides like tirzepatide for longevity and performance, advocating for safer, legal access.

Key Moments

The Peptide Expert: Big Pharma Are Hiding This Powerful Peptide From You! - Dr. Alex Tatem

Q: What are the risks associated with using growth hormone (somatropen)?

While beneficial for sleep and recovery, excessive growth hormone can lead to insulin resistance, acromegaly (abnormal bone growth), and temporary hand numbness. It can also theoretically worsen existing cancers.

The Diary Of A CEO

People & Blogs5 min read90 min video

Apr 20, 2026|255,312 views|10,927|1,180

Save to Pod

Key Moments

TL;DR

Big Pharma is reportedly suppressing powerful, unpatentable peptides that offer widespread health benefits, leading to their classification as "research use only" despite promising trial results.

Key Insights

Peptides are highly targeted "keys" that unlock specific cellular receptors, unlike broad-acting "small molecule" drugs.

The FDA banned 19 peptides in 2023, moving them to "category 2" (forbidden), after previously allowing them to be compounded since 2014.

GLP-1 drugs like semaglutide and tirzepatide, which are peptides, are estimated to generate over $55 billion in revenue this year alone, approaching the revenue of major AI companies.

While research-use-only peptides lack quality control and can be dangerous, the FDA is considering legalizing seven peptides, including BPC-157 and KPV, in July 2023.

Rapid weight loss from GLP-1s can lead to muscle catabolism; myostatin inhibitors are in development to preserve muscle mass during caloric deficits.

Recombinant human growth hormone (somatropin) can improve sleep, skin, hair, and nails, but abuse can lead to insulin resistance and irreversible facial bone structure changes (acromegaly).

Peptides as precision tools for health

Peptides are short chains of amino acids, functioning like highly specific "keys" designed to target particular receptors in the body, in contrast to "small molecule" drugs which are less targeted and can have broader side effects. This specificity makes them incredibly versatile, with applications ranging from anti-aging and tissue repair to metabolic regulation and cognitive enhancement. Historically, insulin (1921) and leuprolide (1985) were early examples of medically significant peptides. The guest explains that peptides work by interacting with specific cellular receptors or pathways, analogous to finding the right lock for a precisely cut key.

The 2023 FDA ban and its aftermath

A significant turning point for peptides occurred in 2023 when the FDA reclassified 19 commonly used peptides from "category 1" (compoundable) to "category 2" (forbidden). This decision, which went into effect overnight, halted their availability through compounding pharmacies. Officially, the FDA cited insufficient data on safety and efficacy, as many of these peptides had not undergone the full, expensive FDA approval process. However, the prevalent theory discussed is that this move benefits Big Pharma, as these peptides are often unpatentable and natural, thus lacking a clear profit incentive for large pharmaceutical companies to pursue FDA approval.

Why Big Pharma might oppose unpatentable peptides

The core issue for large pharmaceutical companies, according to Dr. Tatem, is the profitability of drug development. Since many promising peptides are naturally occurring or difficult to patent, companies have little financial incentive to invest millions of dollars in the lengthy and costly FDA approval process. This creates a market where powerful, beneficial compounds remain inaccessible to the public through conventional channels. Instead, they often end up in the "research use only" market, which lacks quality control and presents safety risks. The interview highlights that the pharmaceutical industry is essentially a profit-driven machine, and while not necessarily "evil," it prioritizes financial returns, sometimes at the expense of patient access to potentially life-changing treatments.

The rise of compounding pharmacies and the "gray market"

Compounding pharmacies historically provided custom-made medications. Post-2013 legislation created a framework where compounding pharmacies could produce substances on a specific FDA list (category 1). This allowed for the legal compounding and prescription of many peptides from 2014 until the 2023 ban. When these peptides were banned, a "gray market" emerged where companies sell products labeled "for research use only." While these can be obtained without a prescription, they bypass FDA oversight, quality control, and standardization, posing significant risks to consumers.

Promising peptides and their varied applications

The discussion covers a range of peptides with diverse functions. BPC-157, a synthetic mimic of a naturally occurring peptide, shows remarkable healing properties, particularly in enhancing blood vessel growth and tissue repair, even demonstrating effectiveness in animal models for severed tendons and being exceptionally well-tolerated. GLP-1 agonists (like semaglutide and tirzepatide) are highlighted for their dramatic impact on weight loss, improving metabolic health, and consequently, for men, significantly boosting sperm count and fertility. Other peptides discussed include GHK-Cu for skin regeneration, Melanotan II for tanning and erectile function, and various growth hormone secretagogues (like CJC-1295 and Ipamorelin) for anti-aging, fat loss, and tissue healing. The potential legalization of seven peptides in July (including BPC-157, TB-500, KPV, MOT-C, DIP, Epitalon, and CAX) has generated significant excitement.

Potential side effects and trade-offs

Despite their benefits, peptides are not without risks and trade-offs. Growth hormone (somatropin), for instance, can improve sleep, skin, and hair, but overuse can lead to insulin resistance, acromegaly (abnormal bone growth), and potentially exacerbate existing cancers. Rapid weight loss from GLP-1s can cause muscle loss (catabolism), leading to the development of myostatin inhibitors to counter this. Epitalon, while explored for longevity by potentially extending telomeres, is viewed with skepticism by the guest regarding its "fountain of youth" claims. The primary current trade-off for many peptides is the lack of a legal, regulated supply, forcing users to rely on "research use only" products with unknown purity and dosage.

The future landscape of peptide therapy

The interview frames peptides as a rapidly advancing frontier in medicine, with significant revenue potential. The market for GLP-1 drugs alone is projected to exceed $55 billion this year, rivaling the revenue of major AI companies. Pharmaceutical giants are actively investing in peptide development, aided by AI, suggesting a future where more peptides will become commercially available. The guest advocates for a return to a legal framework, such as that provided by 503A compounding pharmacies, to ensure safe, regulated access to these powerful compounds, emphasizing the importance of physician consultation for personalized treatment plans.

The broader implications for health and societal well-being

Beyond individual health optimization, the conversation touches on the societal impact of metabolic disease, which is tied to obesity and insulin resistance—leading culprits in conditions like erectile dysfunction and male infertility. Peptides, particularly GLP-1 agonists, offer a potential avenue to combat these issues, as demonstrated by patients significantly improving their fertility and overall health. The discussion also briefly explores the controversial "Enhanced Games" concept, questioning the utility and enforcement of doping rules in sports, and the drastic measures some men resort to for erectile dysfunction, such as penile implants, when other treatments fail. Ultimately, the goal is to make these powerful tools accessible to everyone, not just the elite or wealthy, to improve public health on a large scale.

Mentioned in This Episode

●Supplements

●Products

●Companies

●Organizations

●Drugs & Medications

●Concepts

●People Referenced

Common Questions

Peptides are structural classes of medications made from small pieces of amino acids, acting like specific keys that target certain receptors or pathways within cells. Unlike small molecules with broad effects, peptides are highly targeted.

Topics

Weight Loss Metabolic Health Health & Longevity Science & Mathematics Injury Recovery Drug Development Medicine & Clinical Peptide Therapy Hormone Management FDA Regulations

Mentioned in this video

Drugs & Medications

KPV

A peptide linked to angiogenesis and tissue repair.

MOTC

A peptide referred to as 'exercise in a vial' that improves VO2 max and exercise tolerance by up-regulating ATP production.

CAX

A peptide that affects cognitive function, with potential benefits for improving thinking and studied for outcomes after TBI and stroke.

DIP

A peptide that helps regulate circadian rhythm and sleep cycles.

Epihalon

A peptide that regulates sleep and recovery, and is theoretically expected to be available in July.

IGF-1 LR3

A longer-lasting version of IGF-1, which is a downstream effect of growth hormone and may contribute to muscle mass in higher doses, though not a primary method for significant muscle gain.

Epomoralin

A ghrelin receptor agonist that, when combined with CJC1295, stimulates natural growth hormone release, offering benefits for skin quality, hair, nails, recovery, muscle, and fat loss.

Epialon

A peptide that works to enhance telomerase, potentially playing a role in cellular aging and repair, with some observed benefits in brain regions related to circadian rhythm.

Viagra

An oral medication for erectile dysfunction that may become ineffective over time, leading to side effects like headaches without benefit.

Cialis

An oral medication for erectile dysfunction that may become ineffective over time, leading to side effects like headaches without benefit.

Trenbolone

A substance for veterinary use only that is not FDA-approved, and thus would not be permitted in the Enhanced Games.

Organizations

FDA

The Food and Drug Administration, which is considering legalizing several peptides in July and has previously banned certain peptides deemed too dangerous due to insufficient data.

Supreme Court

Ruled in the Myriad Genetics case, stating that natural substances found within the human body cannot be patented.

Supplements

BPC-157

A synthetic peptide derived from a naturally found peptide in the gut, known for enhancing blood vessel growth and aiding healing after injury. It has shown remarkable results in animal models with very high tolerance.

Thymosin Beta-4

A peptide that aids in angiogenesis and tissue repair.

Companies

Myriad Genetics

A company involved in a 2013 court case where they patented genes associated with breast cancer. The Supreme Court ruled against them, establishing that natural biological material cannot be patented, which inadvertently impacted drug development incentives.

Novo Nordisk

A pharmaceutical company that, along with Lily, produces GLP-1 medications and is reportedly pressuring the FDA to crack down on compounded versions.

Neuralink

A company working on brain-chip interfaces to help people with sensory or motor impairments, such as restoring hearing, sight, or allowing paraplegics to walk.

Concepts

GLP-1

A class of drugs, like semaglutide and tirzepatide, that are effective for weight loss and improving metabolic health, including increasing sperm count as a downstream effect.

Products

GHK-Cu

A topical cream peptide that can improve skin quality by regenerating collagen and elastin, and is legally available for purchase.

People

Elon Musk

The recommended recipient for a hypothetical $1 billion donation due to his work on solving major human problems, including advancements in AI chips via Terrafab and brain-chip interfaces with Neuralink.